港股異動 | 小鵬汽車漲10% 小鵬P9料本月19日亮相
格隆匯11月12日丨小鵬汽車(9868.HK)現漲10.2%,報193.4港元,總市值3310億港元。小鵬汽車旗下第四款車型將於2021廣州車展旗艦亮相。該車定位中大型SUV,預料定名小鵬P9。廣州車展將於本月19日舉行,公司將於當日舉行新聞發佈會。另外,11月12日,廣州小鵬汽車科技有限公司公佈“訂餐處理方法及裝置”專利。摘要顯示,該方法包括:向用户顯示供選擇的訂餐計劃信息,獲取用户從中選擇的配送到車選項、預約時間、送餐數量及餐食內容,並生成預約訂餐訂單。用户可通過本方案提前預約訂餐,預約時間不侷限飯點前且能配送到車,無需與配送員面對面接觸,豐富用户的配送需求,改善用户體驗。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.